Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

NCT06617897 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Fibrinogen Deficiency

Interventions

BIOLOGICAL: CSL511 Fibrinogen concentrate (human)
BIOLOGICAL: Cryoprecipitate

Sponsor

CSL Behring